Journal of Medical Economics

Title Publication Date Language Citations
Hypoglycemia: An overview of fear of hypoglycemia, quality-of-life, and impact on costs2011/01/01English155
The cost burden of multiple sclerosis in the United States: a systematic review of the literature2013/03/07English142
Burden of illness in idiopathic pulmonary fibrosis2012/04/25English141
Comparative financing analysis and political economy of noncommunicable diseases2019/04/08English132
Medication adherence and discontinuation of long-acting injectable versus oral antipsychotics in patients with schizophrenia or bipolar disorder2017/09/29English129
Validation of the Bowel Function Index to detect clinically meaningful changes in opioid-induced constipation2009/11/16English128
Costs of managing severe hypoglycaemia in three European countries2009/10/07English121
Burden of venous leg ulcers in the United States2014/03/24English115
Health outcomes and economic burden of hospitalized COVID-19 patients in the United States2021/01/01English108
Economic burden of venous thromboembolism: a systematic review2011/01/01English108
The cost of osteoporotic fractures in the UK: projections for 2000–20202001/01/01English106
The direct and indirect costs of long bone fractures in a working age US population2012/10/22English89
The effect of pharmacogenetic profiling with a clinical decision support tool on healthcare resource utilization and estimated costs in the elderly exposed to polypharmacy2015/11/11English87
The burden associated with neuropathic pain in Western Europe2012/10/10English86
Therapy persistence and adherence in patients with chronic obstructive pulmonary disease: multiple versus single long-acting maintenance inhalers2011/01/01English85
Clinical comorbidities, treatment patterns, and direct medical costs of patients with osteoarthritis in usual care: a retrospective claims database analysis2011/01/01English85
Medical chart validation of an algorithm for identifying multiple sclerosis relapse in healthcare claims2010/10/01English84
Direct medical costs of complications of diabetes in the United States: estimates for event-year and annual state costs (USD 2012)2014/01/28English81
Impact of medication adherence to disease-modifying drugs on severe relapse, and direct and indirect costs among employees with multiple sclerosis in the US2012/01/01English81
The impact of pain on labor force participation, absenteeism and presenteeism in the European Union2010/11/01English81
Economic impact of severe and non-severe hypoglycemia in patients with Type 1 and Type 2 diabetes in the United States2015/02/11English80
The burden of chronic low back pain with and without a neuropathic component: a healthcare resource use and cost analysis2011/12/05English80
Burden of illness: direct and indirect costs among persons with hemophilia A in the United States2015/03/09English79
Cost-effectiveness of axicabtagene ciloleucel for adult patients with relapsed or refractory large B-cell lymphoma in the United States2018/10/16English79
The societal impact of pain in the European Union: health-related quality of life and healthcare resource utilization2010/09/01English78
Healthcare utilization and cost of systemic lupus erythematosus in a US managed care health plan2013/03/11English78
Persistence with and adherence to fingolimod compared with other disease-modifying therapies for the treatment of multiple sclerosis: a retrospective US claims database analysis2014/07/23English73
Economic burden of contrast-induced nephropathy: implications for prevention strategies2007/01/01English73
The Global South political economy of health financing and spending landscape – history and presence2021/11/16English72
Comparison of historical medical spending patterns among the BRICS and G72015/10/08English71